E Fund Management (HK)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
E Fund Management (HK)'s MRNA Position: Q2 2026 in Review
E Fund Management (HK) increased its Moderna (MRNA) stake by 1,086% in Q2 2026, buying an estimated $154K and bringing the position to 3,249 shares worth $228K. The position accounts for 0.08% of the portfolio, ranked #148.
E Fund Management (HK) first reported a position in MRNA in Q2 2024 and has held it in 4 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- E Fund Management (HK) held 3,249 shares of Moderna worth $228K as of Q2 2026.
- E Fund Management (HK) bought 2,975 Moderna shares in Q2 2026, an estimated $154K.
- Moderna made up 0.08% of E Fund Management (HK)'s portfolio in Q2 2026, its #148 holding.
- E Fund Management (HK) first reported a position in Moderna in Q2 2024 and has held it in 4 quarters since.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.